Holen Sie sich die Stockscreener-App
24.54
2.81%
0.67
Handel nachbörslich:
24.61
0.07
+0.29%
Schlusskurs vom Vortag:
$23.87
Offen:
$23.72
24-Stunden-Volumen:
2.30M
Relative Volume:
0.91
Marktkapitalisierung:
$2.97B
Einnahmen:
$1.12B
Nettoeinkommen (Verlust:
$5.00M
KGV:
2,454.00
EPS:
0.01
Netto-Cashflow:
$-383.00M
1W Leistung:
+3.46%
1M Leistung:
+5.73%
6M Leistung:
+159.96%
1J Leistung:
+210.63%
1-Tages-Spanne:
$23.67
$24.82
1-Wochen-Bereich:
$22.95
$24.82
52-Wochen-Spanne:
$7.62
$25.10
Indivior Plc Stock (INDV) Company Profile
Firmenname
Indivior Plc
Sektor
Telefon
804-379-1090
Adresse
234 BATH ROAD, SLOUGH, BERKSHIRE
Vergleichen Sie INDV mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
INDV
Indivior Plc
|
24.54 | 2.97B | 1.12B | 5.00M | -383.00M | 0.01 |
|
ZTS
Zoetis Inc
|
143.46 | 63.05B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.80 | 43.33B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.17 | 40.43B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.11 | 22.97B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
433.61 | 19.90B | 3.08B | 1.24B | 1.07B | 25.61 |
Indivior Plc Stock (INDV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-06 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-07-22 | Fortgesetzt | Jefferies | Buy |
| 2025-01-28 | Eingeleitet | Rodman & Renshaw | Buy |
| 2024-07-23 | Eingeleitet | Piper Sandler | Overweight |
| 2024-04-03 | Eingeleitet | Craig Hallum | Buy |
| 2023-07-13 | Eingeleitet | Northland Capital | Outperform |
Alle ansehen
Indivior Plc Aktie (INDV) Neueste Nachrichten
Substance Abuse Treatment Market to Witness Remarkable Growth With Indivior PLC, Pfizer, Inc. - openPR.com
Can Indivior PLC stock reach $100 price target2025 Geopolitical Influence & Accurate Buy Signal Alerts - newser.com
Will Indivior PLC stock deliver long term returns2025 Big Picture & Safe Entry Zone Identification - newser.com
News impact scoring models applied to Indivior PLCJuly 2025 Price Swings & Fast Entry Momentum Trade Alerts - newser.com
Chart based exit strategy for Indivior PLCEarnings Trend Report & Scalable Portfolio Growth Methods - newser.com
How Indivior PLC stock performs in rising dollar environment2025 EndofYear Setup & Weekly Market Pulse Alerts - newser.com
Indivior targets $1.5B peak revenue for Sublocade amid 2025 transition plans - MSN
Will Indivior PLC stock rally after Fed decisionsMarket Weekly Review & Weekly Momentum Picks - newser.com
Is Indivior PLC stock reversal real or fakeTrade Volume Report & Risk Controlled Stock Pick Alerts - newser.com
Will Indivior PLC benefit from macro trendsJuly 2025 Analyst Calls & Low Risk Investment Opportunities - newser.com
Strategies to average down on Indivior PLCJuly 2025 Review & Target Return Focused Picks - newser.com
Indivior PLC stock outlook for YEARTrade Exit Summary & Entry Point Confirmation Alerts - newser.com
Will Indivior PLC outperform the marketJuly 2025 Action & Expert Curated Trade Setups - newser.com
What indicators show strength in Indivior PLCTrade Analysis Report & Daily Volume Surge Signals - newser.com
U.S. Suboxone Market Set to See Booming Growth 2025-2032 Driven by Key Players like Indivior, Teva, and Alcami - openPR.com
Substance Abuse Treatment Market Size, Growth Analysis 2031 - openPR.com
What the charts say about Indivior PLC today2025 Risk Factors & Growth-Oriented Investment Plans - newser.com
Indivior Launches Action Agenda for Business Enhancement - MSN
What analysts say about Indivior PLC stockHigh Dividend Yield Stocks & Big Profit Small Budget - earlytimes.in
Automated trading signals detected on Indivior PLC2025 Short Interest & Daily Volume Surge Trade Alerts - newser.com
Full technical analysis of Indivior PLC stockJuly 2025 Short Interest & Safe Capital Growth Trade Ideas - newser.com
Why Indivior PLC stock remains resilient2025 Retail Activity & Safe Investment Capital Preservation Plans - newser.com
Should you wait for a breakout in Indivior PLC2025 Trading Recap & Stock Portfolio Risk Control - newser.com
Can momentum traders help lift Indivior PLCMarket Risk Report & Fast Moving Stock Watchlists - newser.com
Indivior PLC (INDV) Raises 2025 Guidance After Q2 Revenue Hits $302M - MSN
US AG stops misleading marketing of unauthorized opioid overdose drug by Indivior - The Pharma Letter
Indivior plans U.S. domicile shift from U.K. to enhance Nasdaq presence - Investing.com Nigeria
UK's Indivior to re-domicile to US after listing move - Global Banking | Finance | Review
Opvee, High-Profile Overdose Antidote No One Used, Discontinues Marketing - Filter
UK’s Indivior to re-domicile to US after listing move - 104.1 WIKY
Indivior proposes new corporate structure to achieve U.S. domiciliation - MarketScreener
Indivior (INDV) Plans U.S. Domicile Shift with New Parent Compan - GuruFocus
Indivior to pursue a change in domicile from the U.K. to the U.S - TipRanks
Indivior Announces Redomiciliation to U.S. from U.K. - TipRanks
Indivior Proposes New Corporate Structure to Achieve U.S. Domiciliation - WV News
Indivior PLC (INDV) Investor Outlook: Analyzing A 21% Upside In The Healthcare Sector - DirectorsTalk Interviews
Finanzdaten der Indivior Plc-Aktie (INDV)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.90%
2.72%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):